---
schema_version: "secwatch.filing_event.v1"
accession: "0001728117-24-000088"
form_type: "8-K"
ticker: "GOSS"
cik: "0001728117"
company_name: "Gossamer Bio, Inc."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T04:57:43.910576+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Gossamer Bio receives Nasdaq bid-price deficiency notice; deadline March 2025

## Summary
- Nasdaq notified Gossamer Bio that its stock failed to maintain $1.00 minimum bid for 30 consecutive business days through Sept 10, 2024.
- Company has 180 calendar days, until March 10, 2025, to regain compliance by closing at $1.00 for at least 10 consecutive business days.
- If not compliant by March 2025, may transfer to Nasdaq Capital Market for an additional 180-day cure period, subject to other standards.
- Company may consider options such as a reverse stock split but cannot guarantee it will regain compliance.

## SEC filing metadata
- accession: 0001728117-24-000088
- form_type: 8-K
- ticker: GOSS
- cik: 0001728117
- company_name: Gossamer Bio, Inc.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728117/000172811724000088/0001728117-24-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728117/000172811724000088/goss-20240911.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001728117-24-000088
- JSON: https://secwatch.observer/filing/0001728117-24-000088.json
- Plain text: https://secwatch.observer/filing/0001728117-24-000088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.